Anbio Biotechnology Class A Ordinary Shares (NNNN) — Cash Flow Quality Index
Anbio Biotechnology Class A Ordinary Shares (NNNN) has a Cash Flow Quality Index of 0.17x as of June 2024. Operating cash flow of $647.54K is below net income of $3.89 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore NNNN cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Anbio Biotechnology Class A Ordinary Shares Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for Anbio Biotechnology Class A Ordinary Shares across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check NNNN cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Anbio Biotechnology Class A Ordinary Shares (2021–2025)
Year-by-year earnings quality comparison for Anbio Biotechnology Class A Ordinary Shares. For live market cap and the full company financial profile, see NNNN market cap.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -1.05x | $-6.74 Million | $6.40 Million | ▼ -220.0% |
| 2024 | 0.88x | $2.08 Million | $2.37 Million | ▲ +119.9% |
| 2023 | 0.40x | $898.37K | $2.25 Million | ▼ -10.3% |
| 2022 | 0.44x | $4.45 Million | $10.01 Million | ▼ -73.0% |
| 2021 | 1.65x | $4.18 Million | $2.54 Million | — |